Zurueck zur Suche

Reporte zur Charge UJ499AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
IL 1

VAERS 1774849

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ499AB

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
09.10.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient received an expired dose of the FLUZONE HIGH-DOSE QUADRIVALENT, with no adverse event; Initial information was received on 30-Sep-2021 regarding an unsolicited valid non-serious case from a other health professional and consumer or non-healthcare professional via call center via Company (Reference number- 00793324). This case involves a patient of (unknown demographics) who received an expired vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (expired product administered). The patient's medical history, past medical treatment, vaccination and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number: UJ499AB and expiry date: 30-JUN-2021) via an unknown route at an unknown administration site for prophylactic vaccination. It was an actual medication error due to expired vaccine used (latency: same day). At the time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1756421

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ499AB

gering
Staat
-
Alter
67,0
Geschlecht
M
Eingang
02.10.2021
Impfdatum
23.09.2021
Beginn
23.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

expired vaccine being administered to a patient with no adverse event; Initial information was received on 23-Sep-2021 regarding an unsolicited valid non-serious case received from a Nurse and consumer or non-health care professional via Medical Information - 00782397. This case involves 67 years old male patient who was vaccinated with expired dose of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] (Expired product administered). The patient's past medical history, concomitant therapy, medical treatment(s), vaccination(s) and family history were not provided. On 23-Sep-2021, the patient received a dose of 0.7 ml of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number: UJ499AB and expiry date 30-Jun-2021) via intramuscular route in the right deltoid, for prophylactic vaccination. It was reported "Nurse calling in regards to expired FLUZONE HD PFS being administered to a patient. Caller would like to know if the patient needs to be revaccinated, if so when and if it would cause a problem". It was a case of an actual medication error due to expired vaccine used (latency was on same day). At the time of report, no adverse event reported. Outcome of event was unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-